Table5.
Group |
Sertraline + drug
|
N = 14
|
Sertraline + placebo
|
N = 16
|
P-value |
---|---|---|---|---|---|
Item | Frequency | Percent | Frequency | Percent | |
Allergy | 1 | 2.9 % | 1 | 2.9 % | 0.925 |
Asthma | 1 | 2.9 % | 1 | 2.9 % | 0.925 |
Sinus irritation | 1 | 2.9 % | 1 | 2.9 % | 0.925 |
Dermatitis | 1 | 2.9 % | 3 | 8.8% | 0.634 |
Subcutaneous phlebitis | 0 | 0% | 0 | 0% | NS |
Tachycardia | 3 | 8.8% | 3 | 8.8% | 0.861 |
Nausea | 7 | 20.6% | 3 | 8.8% | 0.319 |
Vomiting | 2 | 5.9% | 0 | 0% | 0.165 |
Dizziness | 5 | 14.7% | 2 | 5.9% | 0.155 |
Somnolence | 8 | 23.5% | 7 | 20.6% | 0.481 |
Excessive sedation | 2 | 5.9% | 1 | 2.9 % | 0.493 |
Abnormal bleeding | 0 | 0% | 1 | 2.9 % | 0.333 |
etc. | 3 | 8.8% | 4 | 11.8% | 0.825 |